Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Karas, B. J.
Right arrow Articles by Bauman, A. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Karas, B. J.
Right arrow Articles by Bauman, A. W.
NEUROLOGY 1982;32:428
© 1982 American Academy of Neurology

Valproate tremors

B. J. Karas, Pharm.D., B. J. Wilder, M.D., E. J. Hammond, Ph.D. and A. W. Bauman

Neurology Service, Veterans Administration Medical Center, and the Department of Neurology, University of Florida College of Medicine, Gainesville, FL.

We made accelerometric recordings of the tremor induced by valproic acid. The tremor was similar to essential tremor and appeared within a month of starting therapy. It was present at rest and exacerbated by action or antigravity positioning. There was no close correlation of tremor severity and plasma valproate level, but the tremor usually appeared at dosages greater than 750 mg per day. This tremor has appeared in 20 of 25 patients recently studied. In some patients the tremor is markedly active; however, others note only minimal tremor activity.

Address correspondence and reprint requests to Dr. Wilder, Chief, Neurology Service, Veterans Administration Medical Center. Gainesville, FL 32602.

This work was supported by the Medical Research Service of the Veterans Administration and the Epilepsy Research Foundation of Florida, Inc.

Accepted for publication September 2, 1981.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Zadikoff, R P Munhoz, A N Asante, N Politzer, R Wennberg, P Carlen, and A Lang
Movement disorders in patients taking anticonvulsants
J. Neurol. Neurosurg. Psychiatry, February 1, 2007; 78(2): 147 - 151.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
R Bhidayasiri
Differential diagnosis of common tremor syndromes
Postgrad. Med. J., December 1, 2005; 81(962): 756 - 762.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
R. Guerrini, P. Bonanni, A. Patrignani, P. Brown, L. Parmeggiani, P. Grosse, P. Brovedani, F. Moro, P. Aridon, R. Carrozzo, et al.
Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2
Brain, December 1, 2001; 124(12): 2459 - 2475.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1982 by AAN Enterprises, Inc.